News
| 2 min read
Twirla is reportedly the first contraceptive patch to combine levonorgestrel and ethinyl estradiol
| 2 min read
Black and Hispanic populations’ heightened risk of exposure and transmission is primary factor of impact
| 2 min read
Transcriptome sequencing of patients with liver disease reveals gene expression changes that could help to track disease severity and progression
| 2 min read
The partners' work will focus on biomarker analysis to support clinical development of RGLS4326
| 2 min read
Horizon grants Sanyou two commercial licenses to its CHOSOURCE platform
| 2 min read
Catalyst Biosciences gains FDA Fast Track designation for subcutaneous MarzAA for the treatment of Hemophilia
